Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and

Related Experiment Video

Updated: Jun 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Shmuel Fuchs1, Ran Kornowski, Igal Teplitsky

  • 1Cardiology Department, Rabin Medical Center, Golda-Hasharon Campus, Petach Tikva, Israel. shmuelf@clalit.org.il

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|March 31, 2009
PubMed

Insights

Major bleeding during primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) increases mortality. Female gender and intra-aortic balloon pump use are key risk factors.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Major bleeding is a frequent complication of primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI).
  • Understanding the incidence, predictors, and outcomes of peri-procedural bleeding is crucial for patient management.

Purpose of the Study:

  • To investigate the incidence of major bleeding in patients undergoing primary PCI for STEMI.
  • To identify predictors of major bleeding.
  • To assess the prognostic impact of major bleeding on clinical outcomes.

Main Methods:

  • A cohort of 831 consecutive patients undergoing primary PCI between January 2001 and June 2005 was studied.
  • Major bleeding was defined by specific criteria including hemoglobin drop or transfusion need.
  • Clinical outcomes were evaluated at 30 days and 6 months post-procedure.

Main Results:

  • The incidence of major bleeding was 3.5% (27 patients).
  • Predictors included older age, female gender, cardiogenic shock, higher CADILLAC score, and elevated activated clotting time (ACT).
  • Major bleeding was significantly associated with increased 6-month mortality (37% vs. 10%).

Conclusions:

  • Major bleeding following primary PCI for STEMI is linked to higher 6-month mortality.
  • Female gender and the need for intra-aortic balloon pump (IABP) support are significant risk factors.
  • Close monitoring of anticoagulation may help mitigate bleeding risk.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...